Table 4

When to use non-fasting and fasting blood sampling to assess the plasma lipid profile

Patients for lipid profile testing
Non-fastingIn most patients, including:
  • Initial lipid profile testing in any patient

  • For cardiovascular risk assessment

  • Patients admitted with acute coronary syndromea

  • In children

  • If preferred by the patient

  • In diabetic patientsb (due to hypoglycaemic risk)

  • In the elderly

  • Patients on stable drug therapy

FastingCan sometimes be required if:
  • Non-fasting triglycerides >5 mmol/L (440 mg/dL)

  • Known hypertriglyceridaemia followed in lipid clinic

  • Recovering from hypertriglyceridaemic pancreatitis

  • Starting medications that cause severe hypertriglyceridaemia

  • Additional laboratory tests are requested that require fastingc or morning samples (e.g. fasting glucosec, therapeutic drug monitoring)

Patients for lipid profile testing
Non-fastingIn most patients, including:
  • Initial lipid profile testing in any patient

  • For cardiovascular risk assessment

  • Patients admitted with acute coronary syndromea

  • In children

  • If preferred by the patient

  • In diabetic patientsb (due to hypoglycaemic risk)

  • In the elderly

  • Patients on stable drug therapy

FastingCan sometimes be required if:
  • Non-fasting triglycerides >5 mmol/L (440 mg/dL)

  • Known hypertriglyceridaemia followed in lipid clinic

  • Recovering from hypertriglyceridaemic pancreatitis

  • Starting medications that cause severe hypertriglyceridaemia

  • Additional laboratory tests are requested that require fastingc or morning samples (e.g. fasting glucosec, therapeutic drug monitoring)

aWill need repeated lipid profile testing later because acute coronary syndrome lowers lipid concentrations.

bDiabetic hypertriglyceridaemia may be masked by fasting.

cIn many countries, fasting blood sampling is restricted to very few analytes besides lipid profiles: one example is fasting glucose; however, in many countries, even fasting glucose measurement is being replaced by measurement of haemoglobin A1c without the need to fast.

Table 4

When to use non-fasting and fasting blood sampling to assess the plasma lipid profile

Patients for lipid profile testing
Non-fastingIn most patients, including:
  • Initial lipid profile testing in any patient

  • For cardiovascular risk assessment

  • Patients admitted with acute coronary syndromea

  • In children

  • If preferred by the patient

  • In diabetic patientsb (due to hypoglycaemic risk)

  • In the elderly

  • Patients on stable drug therapy

FastingCan sometimes be required if:
  • Non-fasting triglycerides >5 mmol/L (440 mg/dL)

  • Known hypertriglyceridaemia followed in lipid clinic

  • Recovering from hypertriglyceridaemic pancreatitis

  • Starting medications that cause severe hypertriglyceridaemia

  • Additional laboratory tests are requested that require fastingc or morning samples (e.g. fasting glucosec, therapeutic drug monitoring)

Patients for lipid profile testing
Non-fastingIn most patients, including:
  • Initial lipid profile testing in any patient

  • For cardiovascular risk assessment

  • Patients admitted with acute coronary syndromea

  • In children

  • If preferred by the patient

  • In diabetic patientsb (due to hypoglycaemic risk)

  • In the elderly

  • Patients on stable drug therapy

FastingCan sometimes be required if:
  • Non-fasting triglycerides >5 mmol/L (440 mg/dL)

  • Known hypertriglyceridaemia followed in lipid clinic

  • Recovering from hypertriglyceridaemic pancreatitis

  • Starting medications that cause severe hypertriglyceridaemia

  • Additional laboratory tests are requested that require fastingc or morning samples (e.g. fasting glucosec, therapeutic drug monitoring)

aWill need repeated lipid profile testing later because acute coronary syndrome lowers lipid concentrations.

bDiabetic hypertriglyceridaemia may be masked by fasting.

cIn many countries, fasting blood sampling is restricted to very few analytes besides lipid profiles: one example is fasting glucose; however, in many countries, even fasting glucose measurement is being replaced by measurement of haemoglobin A1c without the need to fast.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close